Loading your page…
5 companies in 4 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
24 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ERZOFRI117mg/0.75ml (117mg/0.75ml) | 156mg/ml (156mg/ml) | 234mg/1.5ml (156mg/ml) | 351mg/2.25ml (156mg/ml) | 39mg/0.25ml (39mg/0.25ml) | 78mg/0.5ml (78mg/0.5ml) · Suspension, extended release | Paliperidone | United States | Marketed | 2024 |
| RYKINDO12.5mg | 25mg | 37.5mg | 50mg · For suspension, extended release | Risperidone | United States | Marketed | 2023 |
| RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 25MG/VIAL25mg/vial · Injection, suspension, extended release | Risperidone | Singapore | Authorised | 2025 |
| RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL37.5mg/vial · Injection, suspension, extended release | Risperidone | Singapore | Authorised | 2025 |
| RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 50MG/VIAL50mg/vial · Injection, suspension, extended release | Risperidone | Singapore | Authorised | 2025 |
| SEROQUEL TABLET 100 mg100 mg · Tablet, film coated | Quetiapine | Singapore | Authorised | 1998 |
| SEROQUEL TABLET 200 mg200 mg · Tablet, film coated | Quetiapine | Singapore | Authorised | 1998 |
| SEROQUEL TABLET 25 mg25 mg · Tablet, film coated | Quetiapine | Singapore | Authorised | 1998 |
| SEROQUEL TABLET 300mg300 mg · Tablet, film coated | Quetiapine | Singapore | Authorised | 2007 |
| Seroquel XR Tablet 150 mg150 mg · Tablet, extended release | Quetiapine | Singapore | Authorised | 2011 |
| Seroquel XR Tablet 200mg200 mg · Tablet, extended release | Quetiapine | Singapore | Authorised | 2008 |
| Seroquel XR Tablet 300mg300 mg · Tablet, extended release | Quetiapine | Singapore | Authorised | 2008 |
| Seroquel XR Tablet 400mg400 mg · Tablet, extended release | Quetiapine | Singapore | Authorised | 2008 |
| Seroquel XR Tablet 50mg50 mg · Tablet, extended release | Quetiapine | Singapore | Authorised | 2008 |
| ZEYZELF® TWICE WEEKLY TRANSDERMAL PATCH 4.6MG/24H25.92mg · Patch, extended release | Rivastigmine | Singapore | Authorised | 2025 |
| ZEYZELF® TWICE WEEKLY TRANSDERMAL PATCH 9.5MG/24H51.84mg · Patch, extended release | Rivastigmine | Singapore | Authorised | 2025 |
| TRIVACIN 4.6MG/24H TRANSDERMAL PATCHES | Rivastigmine | Saudi Arabia | Authorised | |
| TRIVACIN 9.5MG/24H TRANSDERMAL PATCHES | Rivastigmine | Saudi Arabia | Authorised | |
| ROTIGOTINA LUYE 1 MG/24 H PARCHES TRANSDERMICOS EFG1 mg/24 h · Parche transdérmico | Rotigotine | Spain | Withdrawn | 2024 |
| ROTIGOTINA LUYE 2 MG/24 H PARCHES TRANSDERMICOS EFG2 mg/24 h · Parche transdérmico | Rotigotine | Spain | Withdrawn | 2024 |
| ROTIGOTINA LUYE 3 MG/24 H PARCHES TRANSDERMICOS EFG3 mg/24 h · Parche transdérmico | Rotigotine | Spain | Withdrawn | 2024 |
| ROTIGOTINA LUYE 4 MG/24 H PARCHES TRANSDERMICOS EFG4 mg/24 h · Parche transdérmico | Rotigotine | Spain | Withdrawn | 2024 |
| ROTIGOTINA LUYE 6 MG/24 H PARCHES TRANSDERMICOS EFG6 mg · Parche transdérmico | Rotigotine | Spain | Withdrawn | 2024 |
| ROTIGOTINA LUYE 8 MG/24 H PARCHES TRANSDERMICOS EFG8 mg/24 h · Parche transdérmico | Rotigotine | Spain | Withdrawn | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Singapore | 14 | 14 | 0 | CompaniesAll medicines |
| Spain | 6 | 0 | 6 | CompaniesAll medicines |
| Saudi Arabia | 2 | 2 | 0 | CompaniesAll medicines |
| United States | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Serbia, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.
